U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Vita Pure Inc - 524473 - 01/14/2020
  1. Warning Letters

CLOSEOUT LETTER

Vita Pure Inc MARCS-CMS 524473 —

Product:
Dietary Supplements
Recipient:
Recipient Name
Mr. Achyut Sahasra
Recipient Title
President and Owner
Vita Pure Inc

410 West 1st Avenue
Roselle, NJ 07203
United States

Issuing Office:
Baltimore District Office

United States

Dear Mr. Sahasra:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter issued on November 8, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Andrew Ciaccia
Compliance Officer
Human and Animal Food East, Division II

Back to Top